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Background: Fungal infection has become a serious public
health problem in the last two decades. In order to search for alter-
native treatment, the in vitro antifungal activities of extracts from
Uvaria angolensis,Uvariamuricata (Annonaceae), and Terminalia cat-
appa (Combretaceae) was evaluated and their optimization with
Nystatin and Ketoconazole was done.
Methods & Materials: Leaves, twigs and stem of plants were
subjected to aqueous and ethanolic extraction. Agar dilution
method was used to screen the antifungal activities. The phy-
tochemical screening of the most active was done followed
liquid-liquid partition to obtain fractions. Broth microdilution
method and subculture were used to determine their antifungal
parameters (MIC and MFC). The most active extracts were selected
and their combination with antifungal agents assayed in order to
optimize their activities.
Results:Theyieldsof theextractionvaried from3.21% to20.54%.
Nine extracts were selected after preliminary antifungal screening.
The phytochemical screening revealed the presence of phenols,
ﬂavonoids, anthocyanins, essential oils, triterpenes, steroids and
saponins. The extract from leaves of Terminalia catappa showed
the best antifungal activitywithMIC of 1.56mg/ml, 0.78mg/ml and
0.78mg/ml respectively on Candida albicans, Cryptococcus neofor-
mans and Candida parapsilosis isolated from HIV patients. The most
sensitive isolate was C. parapsilosis and the least sensitive was C.
albicans. The interaction study of the combination of the promis-
ing extracts with Nystatin and Ketoconazole presented synergistic
effects with the best index being FICI: 0.17±0.09 from Termina-
lia catappa’s extract on Candida albicans and asigniﬁcant reduction
of the MIC values of the extracts, Nystatin (3 to 1600 times) and
Ketoconazole (2 to 512 times).
Conclusion: These results support the traditional use of these
plants in the treatment of infectious diseases and suggest that they
could serve as potential sources of antifungal. They also showed
that the combination of these extracts with antifungal drugs offers
signiﬁcant potential for the development of novel antifungal ther-
apies.
http://dx.doi.org/10.1016/j.ijid.2014.03.1019
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Background: The purpose of this study is develop a typology
of candida species produced from patient samples, and determine
their in-vitro antifungal susceptibility.
Methods & Materials: In this study, Candida species isolated
from patients who applied to our laboratory between 2009-2010
were included in order to identify the types of Candida and to carry
out their antifungal sensitivity. The Candida species were were
typed using germ tube test, cornmeal Tween-80 and BBL CHROMa-
gar medium, and API ID32C yeast identiﬁcation system. Antifungal
susceptibility of Candida species for amphotericin B, ﬂuconazole,
itraconazole, and voriconazole were conducted through microdi-
lution system.
Results: Of the 97 Candida species, 58.76% were identiﬁed
as Candida albicans, other identiﬁed types were as follows: C.
parapsilosis (13.4%), C. glabrata (11.3%), C. tropicalis (5.15%) respec-
tively. As for the antifungal sensitivity tests, results revealed 1.03%
resistance to ﬂuconazole and 4.12% to itraconazole, whereas no
resistance was found to amphotericin B and voriconazole.
Conclusion: Target population for Candida has gradually been
expanding. Therefore, it may be suggested that determining the
type of pathogen and running its susceptibility tests are signiﬁ-
cant factors that will enhance the success of the treatment before
empirical treatment against Candida infections is initiated.
http://dx.doi.org/10.1016/j.ijid.2014.03.1020
